Impact of Comorbid Constipation on the Survival of Patients with Heart Failure: a Multicenter, Prospective Cohort Study Conducted in Japan

Overview

Journal Front Cardiovasc Med

Date 2025 Jan 29

PMID 39877026

Authors

Tomoaki Ishida

Kei Kawada

Kohei Jobu

Tomoyuki Hamada

Toru Kubo

Moemi Okazaki

Kazuya Kawai

Yoko Nakaoka

Toshikazu Yabe

Takashi Furuno

Eisuke Yamada

Hiroaki Kitaoka

Yukihiro Hamada

Affiliations

Soon will be listed here.

Abstract

Background: Constipation frequently affects heart failure patients because of medication side effects and physiological effects of the condition. Although recent speculation suggests that comorbid constipation may affect cardiovascular disease onset and survival rates, this relationship remains unclear. We examined the effect of comorbid constipation on the survival of patients with heart failure.

Methods: We conducted a multicenter prospective cohort study (the Kochi YOSACOI study) of patients hospitalized for acute decompensated heart failure. The influence of comorbid constipation on survival was evaluated using Cox regression analysis with 2-year survival as the index. Patients were divided into two groups based on the presence of comorbid constipation. The patient background was adjusted using propensity score matching, and the evaluation included assessing the 2-year survival and cardiovascular mortality occurrence using the log-rank test.

Results: Among 1,061 patients hospitalized for acute decompensated heart failure, 715 with complete data (124 with comorbid constipation and 591 without) were analyzed. Comorbid constipation was identified as a risk factor for poorer survival in the Cox regression model (hazard ratio: 1.90, 95% confidence interval: 1.3-2.8, < 0.001). Propensity score matching included 104 patients in each group. Survival analysis using the log-rank test indicated worse survival ( = 0.023) and higher cardiovascular mortality ( = 0.043) in the comorbid constipation group.

Conclusion: Constipation can negatively affect the survival of patients with heart failure. Although the causal link between constipation and decreased survival remains unclear, identifying comorbid constipation is essential for identifying heart failure patients at a higher risk of poor outcomes.

References

Kaplon-Cieslicka A, Soloveva A, Mareev Y, Cabac-Pogorevici I, Verbrugge F, Vardas P . Hyponatraemia in heart failure: time for new solutions?. Heart. 2021; 108(15):1179-1185. DOI: 10.1136/heartjnl-2021-320277. View

Mullens W, Damman K, Harjola V, Mebazaa A, Brunner-La Rocca H, Martens P . The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019; 21(2):137-155. DOI: 10.1002/ejhf.1369. View

Namiuchi S, Tanita A, Sunamura S, Onodera K, Ogata T, Noda K . Effect of constipation on readmission for heart failure in patients with acute heart failure. ESC Heart Fail. 2023; 11(2):819-825. PMC: 10966257. DOI: 10.1002/ehf2.14650. View

Wickham R . Managing Constipation in Adults With Cancer. J Adv Pract Oncol. 2018; 8(2):149-161. PMC: 5995490. View

Rodriguez M, Hernandez M, Cheungpasitporn W, Kashani K, Riaz I, Rangaswami J . Hyponatremia in Heart Failure: Pathogenesis and Management. Curr Cardiol Rev. 2019; 15(4):252-261. PMC: 8142352. DOI: 10.2174/1573403X15666190306111812. View

Rao S, Meduri K . What is necessary to diagnose constipation?. Best Pract Res Clin Gastroenterol. 2011; 25(1):127-40. PMC: 3063397. DOI: 10.1016/j.bpg.2010.11.001. View

Hamada T, Kubo T, Kawai K, Nakaoka Y, Yabe T, Furuno T . Frailty interferes with the guideline-directed medical therapy in heart failure patients with reduced ejection fraction. ESC Heart Fail. 2022; 10(1):223-233. PMC: 9871689. DOI: 10.1002/ehf2.14163. View

McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Bohm M . Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With.... Eur Heart J. 2021; 42(48):4901. DOI: 10.1093/eurheartj/ehab670. View

Chen Y, Sung S, Cheng H, Huang W, Wu C, Huang C . Performance of AHEAD Score in an Asian Cohort of Acute Heart Failure With Either Preserved or Reduced Left Ventricular Systolic Function. J Am Heart Assoc. 2017; 6(5). PMC: 5524056. DOI: 10.1161/JAHA.116.004297. View

10.

Reddy Y, Borlaug B, Gersh B . Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction. Circulation. 2022; 146(4):339-357. DOI: 10.1161/CIRCULATIONAHA.122.057444. View

11.

Guder G, Stork S . COPD and heart failure: differential diagnosis and comorbidity. Herz. 2019; 44(6):502-508. DOI: 10.1007/s00059-019-4814-7. View

12.

Salmoirago-Blotcher E, Crawford S, Jackson E, Ockene J, Ockene I . Constipation and risk of cardiovascular disease among postmenopausal women. Am J Med. 2011; 124(8):714-23. PMC: 3144272. DOI: 10.1016/j.amjmed.2011.03.026. View

13.

Forootan M, Bagheri N, Darvishi M . Chronic constipation: A review of literature. Medicine (Baltimore). 2018; 97(20):e10631. PMC: 5976340. DOI: 10.1097/MD.0000000000010631. View

14.

Sandek A, Swidsinski A, Schroedl W, Watson A, Valentova M, Herrmann R . Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. J Am Coll Cardiol. 2014; 64(11):1092-102. DOI: 10.1016/j.jacc.2014.06.1179. View

15.

Maiuolo J, Carresi C, Gliozzi M, Mollace R, Scarano F, Scicchitano M . The Contribution of Gut Microbiota and Endothelial Dysfunction in the Development of Arterial Hypertension in Animal Models and in Humans. Int J Mol Sci. 2022; 23(7). PMC: 8999124. DOI: 10.3390/ijms23073698. View

16.

Austin P . Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009; 28(25):3083-107. PMC: 3472075. DOI: 10.1002/sim.3697. View

17.

Wei L, Ji L, Miao Y, Han X, Li Y, Wang Z . Constipation in DM are associated with both poor glycemic control and diabetic complications: Current status and future directions. Biomed Pharmacother. 2023; 165:115202. DOI: 10.1016/j.biopha.2023.115202. View

18.

Angkananard T, Anothaisintawee T, Eursiriwan S, Gorelik O, McEvoy M, Attia J . The association of serum magnesium and mortality outcomes in heart failure patients: A systematic review and meta-analysis. Medicine (Baltimore). 2016; 95(50):e5406. PMC: 5268025. DOI: 10.1097/MD.0000000000005406. View

19.

Lucak S, Lunsford T, Harris L . Evaluation and Treatment of Constipation in the Geriatric Population. Clin Geriatr Med. 2020; 37(1):85-102. DOI: 10.1016/j.cger.2020.08.007. View

20.

Branca L, Sbolli M, Metra M, Fudim M . Heart failure with mid-range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines. ESC Heart Fail. 2020; 7(2):381-399. PMC: 7160484. DOI: 10.1002/ehf2.12586. View